Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Sysmex (SSMXF)Sysmex (6869.T): Upgrade to Buy: Time to re-evaluate medium-/long-term stable growth prospects as one-offs priced in 9 October 2025 | 6:47PM JST We upgrade Sysmex shares to Buy (from Neutral) as we see shares entering a phase in which medium- to long- term growth expectations are re-evaluated, following confirmation of an earnings bottom (improvement from the previous quarter) and a possible downward revision to FY3/26 guidance at 2Q3/26 results (scheduled for November 5). While earnings uncertainty lingers, mainly for the China business, we think concerns are now largely priced in with upside support from the stock's underperformance since April (-34% vs. TOPIX's +22%). the current share price looks cheap historically and versus peers.